Searched for
AUGMENTIN
GSK's antibiotic drug Augmentin is India's highest-selling brand with Rs 80 crore monthly saleEnhertu, a cancer drug by AstraZeneca, was the top-selling new drug in 2024 with sales of nearly Rs 58 crore. Over 3,100 new brands were la...17 Feb, 2025, 01.05 PM IST- Plant for production of Penicillin G & Clavulanic acid to start soon: Department of PharmaceuticalsThe Department of Pharmaceuticals has announced that India will soon start producing Clavulanic Acid, a key ingredient in the antibiotic Au...10 Sep, 2024, 01.05 PM IST
- India starts making key API clavulanic acidIndia has begun producing clavulanic acid, a key ingredient in the antibiotic Augmentin, reducing its reliance on China for APIs. Mumbai-ba...06 Sep, 2024, 01.06 AM IST
- Domestic pharmaceutical retail market grows 11 per cent in JulyThe domestic pharmaceutical retail market saw an impressive 11% growth in July, attributed to increased sales of anti-infectives and pain r...16 Aug, 2024, 04.12 PM IST
- Pharma market grows 9.5% in JanuaryThe Indian pharmaceutical market (IPM) saw a robust growth of 9.5% in January with all major therapy areas recording double-digit growth. A...16 Feb, 2024, 12.11 AM IST
- Indian pharma market grows over 9 per cent in DecemberAmong the top therapies, cardiac, anti-infectives and neuro/central nervous system have shown a relatively stronger volume growth last mont...10 Jan, 2024, 09.02 AM IST
- GSK's Augmentin is India's no.1 drug brandResearch firm PharmaTrac data shows Augmentin sales at Rs 801 crore from November 2022-23. For the month of November, Augmentin sales stood...09 Dec, 2023, 12.40 AM IST
- Indian pharma market grew 12.1% in August, AWACS reportThe wholesale price index (WPI) inflation linked price hike allowed by the government has helped the pharma industry to increase by 10% on ...05 Sep, 2022, 07.15 PM IST
- Indian pharma market grew 14.1% in July, AIOCD reportThe fastest growing categories are respiratory which grew at 22.3%, gynaecology - 24%, chemotherapy - 28.4%, urology - 22.5%, ophthalmic - ...05 Aug, 2022, 07.36 PM IST
- Reduce GSK Pharma, target Rs 2483: NomuraHowever, the market expects strong revival in EBITDA margins and the stock is factoring in possible delisting if parent Glaxo Plc buys back...07 Jul, 2016, 01.24 PM IST
- Drug companies, distributors slugfest over marginsDrugmakers from GlaxoSmithKline to Lupin are grappling with distributors, whose demand for maintaining commissions threatens to erode profi...07 Nov, 2013, 04.10 AM IST
- For cheaper drug options, send SMSYou would soon be able to find the most affordable alternative to the medicine prescribed by your doctor through an SMS-based service.17 Jul, 2012, 04.16 AM IST
- Dr Reddy's acquires GSK's US penicillin facilityDr Reddy's Laboratories has acquired GlaxoSmithKline's US penicillin manufacturing facility and the rights to the Augmentin and Amoxil bran...30 Mar, 2011, 02.16 PM IST
- Dr Reddy’s buys GSK’s oral penicillin facility in USDr Reddy’s Laboratories, one of the country’s biggest drug firms, has bought GlaxoSmithKline’s oral penicillin facility and products in the...24 Nov, 2010, 01.34 AM IST
- Prices of antibiotics may flare up 50%A government proposal to slap anti-dumping duties on Chinese and Mexican imports of two key pharma ingredients will push up the prices of c...22 Feb, 2010, 01.46 AM IST
- Wockhardt climbs 5% on USFDA nodShares of drugmaker Wockhardt rose more than 5 per cent after its subsidiary in the US had won approval from FDA to market augmentin suspen...05 Dec, 2008, 10.52 AM IST
- Ranbaxy gets US nod to mkt its drugGurgaon-based pharmaceutical major Ranbaxy Labs today announced that RLL has received approval from the US Food and Drug Administration to ...31 Jan, 2007, 10.40 PM IST
Load More
